Dhaka, March 10 -- Pharmaceutical companies in Bangladesh have been engaging in unethical practices, resulting in significant repercussions for public health.
These practices include lavish gifting to physicians, hospitals, clinics, diagnostic centres, and government officials, leading to inflated medicine prices and compromised quality.
Public health experts have noted that many physicians have failed to maintain professional integrity, succumbing to the pressures imposed by pharmaceutical companies.
These companies aggressively target not only individual doctors but also medical institutions and their personnel with enticing gifts and incentives.
This pervasive influence of pharmaceutical companies has detrimental effects on the medic...